A prospective pilot study of pharmacogenetic based dosing of 5-fluouracil and Irinotecan in patients with gastrointestinal (GI) malignancies.

Presenter Information

J. Chi MDFollow
S. Chung MD
N. Hakim DO
H. Rehman MD
L. Moriarty NP
J. Jose NP

Facility

NS/LIJ

Department

Division of Hematology/Oncology, Department of Medicine

Status

Fellow

Category

Clinical Science Research

Start Date

2-6-2021 12:00 AM